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The past two decades of angiogenesis research have identified a wealth of pro- and antiangiogenic signals
originating from the tissue environment, which control blood vessel density and function. Understanding
when and how blood vessels respond to the combination of signals they encounter to achieve a balanced
cellular response is a major challenge for the field of developmental and tumor angiogenesis. This review
focuses on how endothelial cell-cell communication via the Notch pathway contributes to this signal integra-
tion and is essential for functional vessel patterning.Blood vessel formation supports tissue growth and organ func-
tion in development, physiology, and disease. An insufficient
supply of nutrients and oxygen prompts the formation of new
vessels from the walls of existing vessels in a process termed
angiogenic sprouting. Hypoxic tissues secrete growth factors
and chemokines that stimulate the endothelial cells to break
out of their stable position in the vessel wall and jointly
coordinate sprouting, branching, and new lumenized network
formation, until supply meets demand and quiescence can be
re-established (see also Fraisl et al., 2009 [this issue of Develop-
mental Cell]). Once it is initiated by environmental growth factor
signals, the sprouting process is spearheaded by leading endo-
thelial tip cells (Gerhardt et al., 2003) (Figure 1). Stimulated by
vascular endothelial growth factor-A (VEGF-A), these cells
produce long, dynamic filopodia studded with the tyrosine
kinase receptor VEGFR2/KDR/Flk-1 and other receptors, which
they use to probe the environment for directional cues. The
endothelial cells that follow the tip cells, termed stalk cells,
produce fewer filopodia and instead proliferate when stimulated
with VEGF-A (Gerhardt et al., 2003). They also form the vascular
lumen (see Iruela-Arispe and Davis, 2009 [this issue of Develop-
mental Cell]), and they establish adherens and tight junctions to
maintain the integrity of the new sprout (see Dejana et al., 2009
[this issue of Developmental Cell]) and to establish luminal/ablu-
minal polarity, which, in turn, leads to basal lamina deposition
and mural cell recruitment/attachment. Endothelial tip and stalk
cells also differ in their gene expression profile; tip cells express
Pdgfb, Dll4, Unc5b, Kdr, and Flt4 more strongly than stalk cells
(Claxton and Fruttiger, 2004; Gerhardt et al., 2003; Lu et al.,
2004; Siekmann and Lawson, 2007; Tammela et al., 2008).
These differences are quantitative and most prominent at the
mRNA level. It is important to note that no single gene identified
thus far can serve as a unique marker of tip cells. Nevertheless,
these quantitative differences in gene expression support the
idea that tip and stalk cells have specialized functions during
sprouting angiogenesis. Each new sprout eventually connects
with adjacent sprouts via the tip cell to form a continuous lumen
and thus establish flow in the new vascular loop (Blum et al.,
2008; Leslie et al., 2007). Establishment of flow and basement
membrane and mural cell recruitment all contribute to the
remodeling and maturation of the new vascular connection
(Jain, 2003; Jones et al., 2006; le Noble et al., 2004; Lucitti
et al., 2007). Flow-dependent tissue oxygenation finally downre-196 Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc.gulates paracrine VEGF-A production, and thus helps establish
a quiescent state for the new vessels.
Not all connections remain stable, however, as extensive
remodeling reshapes the primitive plexus (Fruttiger, 2007).
Vascular remodeling, involving the regression of branches,
some new sprouting, and vessel splitting by intussusceptive
growth, is regulated by hemodynamic forces and crosstalk
between the endothelial cells, mural cells, and the tissue environ-
ment (Djonov et al., 2002; Jain, 2003; le Noble et al., 2005; Lucitti
et al., 2007). Regression of vessel branches, the so-called
‘‘pruning’’ process, involves the disassembly of junctions,
followed by cell retraction and, to a variable extent, also endo-
thelial cell apoptosis (Baffert et al., 2006; Hughes and Chang-
Ling, 2000).
What controls the specification of endothelial tip and stalk
cells, how is tip cell migration and protrusive activity regulated,
what controls the number of stalk cells and their proliferation,
how do tip cells communicate during the formation of new
connections, and what determines which connections will
regress during pruning? All of these processes are under the influ-
ence of environmental signals, but to achieve an organized and
functional vessel network, individual endothelial cell responses
need to be coordinated into a team effort. The list of factors
capable of eliciting an angiogenic response is steadily growing;
some of these factors take a center stageposition, whereas others
play more auxiliary roles. The ‘‘principal dancer’’ is VEGF-A, which
promotes endothelial cell differentiation, migration, and prolifera-
tion; controls endothelial cell-cell junctions; suppresses
apoptosis, and more. Many other pathways, including Angiopoie-
tin/Tie2, Notch, Wnt, TGFb/Alk1, FGF, S1P/Edg1, Slit/robo, Sem-
aphorin/Plexin, Netrin/Unc5b, cell matrix/integrin signaling, and
others, regulate the angiogenic response. Over thepast few years,
it has become clear that the Notch signaling pathway plays a key
role in coordinating multiple aspects of endothelial behavior
during vessel patterning and thus in shaping the formation and
remodeling of the vascular network.
The Notch Pathway in Endothelial Cells
The Notch pathway is an evolutionarily conserved signaling
system that is required for normal embryonic development, the
regulation of tissue homeostasis, and the maintenance of stem
cells in adults (Artavanis-Tsakonas et al., 1999; Gridley, 1997)
(Figure 2). The pathway was originally identified in Drosophila,
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then, proteins of the Notch pathway have been discovered in
virtually all metazoans and have been studied extensively in flies,
worms, and vertebrates. These studies have unraveled the
multiple roles of Notch signaling in cell fate specification, tissue
patterning, and morphogenesis through effects on differentia-
tion, proliferation, survival, and apoptosis (Bray, 2006; Fiuza
and Arias, 2007).
In mammals, there are five canonical DSL (Delta, Serrate,
LAG-2) ligands: Delta-like 1 (Dll1), Delta-like 3 (Dll3), Delta-like 4
Figure 1. Phenotypic and Molecular Differences between Endothelial Tip and Stalk Cells
Tip cells (green) head each vascular sprout stimulated by an extracellular VEGF-A gradient (orange), and the following endothelial cells (purple) form the lumenized
stalk.
Figure 2. The Notch Signaling Pathway
The Notch receptor is expressed on the cell
surface as a heterodimeric receptor. The extracel-
lular and membrane-bound intracellular fragments
of Notch are held together through noncovalent
interactions. Upon ligand binding, DSL ligand-
mediated endocytosis nonenzymatically dissoci-
ates the Notch heterodimer (Nichols et al., 2007).
The Notch extracellular domain is transendocy-
tosed into the signal-sending cell, exposing the
remaining membrane-bound receptor to ADAM
and g-secretase proteolysis for release of the
NICD. The NICD translocates to the nucleus to
trigger transcriptional activation of Notch target
genes. CSL, CBF, Suppressor of hairless, LAG-1;
DSL, Delta, Serrate, LAG-2; HDAc, Histone deace-
tylase; MAML, Mastermind-like; HAc, Histone
acetyltransferase; NECD, Notch extracellular
domain; NICD, Notch intracellular domain;
ADAM, a disintegrin and metalloprotease; Ub,
ubiquitin.
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Review(Dll4), Jagged-1 (Jag1), and Jagged-2 (Jag2).(Figure 2) These
ligands are type 1 cell-surface proteins with multiple tandem
epidermal growth factor (EGF) repeats in their extracellular
domains (ECDs). DSL ligands bind to Notch receptors, which
are large (300 kDa), single-pass, type I transmembrane recep-
tors. In mammals, there are four Notch receptors, Notch1 to
Notch4. Binding of a DSL ligand to the ECD of Notch receptor
(NECD) triggers a series of proteolytic cleavages of Notch, first
by a member of the disintegrin and metalloproteases (ADAM)
family within the juxtamembrane region, followed by g-secretase
within the transmembrane domain. The final cleavage releases
the Notch intracellular domain (NICD) from the cell membrane,
which translocates to the nucleus and directly interacts with
the transcription factor CSL (named after mammalian CBF1,
Drosophila Su(H), and Caenorhabditis elegans LAG1), which
binds to the sequence 50-TTCCCAC-30. In the absence of
NICD, CSL represses transcription through interactions with
a corepressor complex that contains a histone deacetylase
(Kao et al., 1998). Binding of the NICD to CSL displaces the
corepressor complex and replaces it with a transcriptional acti-
vation complex that includes the NICD, Mastermind-like
(Maml, a transcriptional coactivator for Notch receptors), and
histone acetyltransferases such as p300 to turn on the expres-
sion of Notch target genes such as the basic helix-loop-helix
(bHLH) proteins Hairy/Enhancer of Split (Hes), Hes-related
proteins (Hey/HRT/HERP), and Notch-regulated ankyrin repeat
protein (Nrarp, discussed in more detail in the section ‘‘Notch
Signaling and Vessel Stability’’). Proteins encoded by the Hes
and Hey genes are, in turn, transcriptional repressors of both
their own expression and further downstream genes.
Several Notch receptors, ligands, and signaling pathway
components have been identified in endothelial cells in vitro
and in vivo, during development and tumor angiogenesis (for
details, see the recent comprehensive reviews [Gridley, 2007;
Hofmann and Iruela-Arispe, 2007; Roca and Adams, 2007]). Of
the Notch receptors, Notch1 and Notch4 are expressed by
endothelial cells; among the DSL ligands, Dll1, Dll4, Jag1, and
Jag2 are expressed by endothelial cells (Claxton and Fruttiger,
2004; Favre et al., 2003; Hofmann and Iruela-Arispe, 2007; Villa
et al., 2001). Key signaling components expressed in endothelial
cells include Rbpj (Dou et al., 2008), Hey1, Hey2 (Fischer et al.,
2004; Iso et al., 2002; Taylor et al., 2002), Maml1 (Liu et al.,
2006), Numb (Favre et al., 2003), and Nrarp (Krebs et al., 2001;
Phng et al., 2009). Functional studies using gene targeting in
mice, mutagenesis and knockdown in zebrafish, and biochem-
ical analysis in cultured endothelial cells have demonstrated
that Notch signaling plays a fundamental role in many aspects
of endothelial cell biology during angiogenesis (see Table 1).
Notch Signaling and Endothelial Cell Specification
Endothelial cells are heterogeneous in morphology, function,
and gene expression. Depending on their state of activation,
their position in the vascular bed, and the organ context, endo-
thelial cells are specified toward particular roles (Aird, 2007).
Lineage tracing, grafting, flow rerouting, and cell culture experi-
ments suggest that heterogeneous endothelial cell specification
is likely dynamic, and that differentiated cells retain a surprising
degree of plasticity (Aitsebaomo et al., 2008; Kudo et al., 2007;
Lacorre et al., 2004; le Noble et al., 2005; Moyon et al., 2001).198 Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc.Notch signaling controls multiple aspects of endothelial cell
specification, such as early specification of a subset of angio-
blasts from the lateral mesoderm during formation of the dorsal
aorta in chicken embryos (Sato et al., 2008) and angioblast
specification, migration, and maintenance through snrk-1 and
gridlock in zebrafish (Chun et al., 2008; Zhong et al., 2001).
Dll4/Notch signaling also controls subsequent endothelial cell
specification toward the arterial or venous phenotype in zebra-
fish and mouse(Carlson et al., 2005; Duarte et al., 2004; Kim
et al., 2008; Lawson et al., 2001, 2002; Zhong et al., 2001).
Targeted deletion of Dll1, Dll4, Notch1, Notch4, Rbpj, and
Hey1 and Hey2 in the mouse (Carlson et al., 2005; Duarte
et al., 2004; Fischer et al., 2004; Gale et al., 2004; Kim et al.,
2008; Krebs et al., 2000, 2004; Limbourg et al., 2007; Trindade
et al., 2008) and knockdown of notch3, gridlock, rbpja, and
mind bomb in the zebrafish (Lawson et al., 2001; Siekmann
and Lawson, 2007; Zhong et al., 2001) result in the deregulation
of arterial and venous specification of endothelial cells as well as
in the deformation of arteries and veins. In this process, Notch
signaling interacts in a genetically defined pathway with
VEGFR2, PLC-g1, MAPK, and EphrinB2/EphB4 signaling to
balance the number and proper assembly of arterial and venous
endothelial cells into distinct vascular tubes with an adequate
diameter (Hong et al., 2006). EphrinB2, which marks arterial
identity, is a direct transcriptional target of Notch (Grego-Bessa
et al., 2007). These studies also suggested that the venous
phenotype is effectively a default choice, and an arterial pheno-
type is acquired through active Notch signaling. However, the
venous transcription factor COUP-TFII appears to actively
repress the arterial marker Neuropilin-1 (Nrp-1) and Notch
signaling. Accordingly, loss of COUP-TFII leads to expansion
of the arterial cell fate during early mouse embryonic develop-
ment, challenging the idea of a venous identity by default (You
et al., 2005).
Recent studies in the mouse retina, in zebrafish interseg-
mental vessels, in tumor angiogenesis, and in 3D endothelial
cell culture sprouting assays demonstrate that the specification
of endothelial cells into tip and stalk cells is regulated by Dll4/
Notch signaling (Hellstrom et al., 2007; Leslie et al., 2007; Lobov
et al., 2007; Noguera-Troise et al., 2006; Ridgway et al., 2006;
Sainson et al., 2005; Siekmann and Lawson, 2007; Suchting
et al., 2007) (Figure 3). Dll4 is most prominently expressed in
tip cells (Claxton and Fruttiger, 2004; Hellstrom et al., 2007),
whereas the strongest Notch signaling activity is regularly
observed in the stalk cells (Hellstrom et al., 2007; Hofmann
and Iruela-Arispe, 2007). Suppression of Notch signaling by
g-secretase inhibitor (GSI) treatment or genetic deletion of one
Dll4 allele in the mouse dramatically augments sprouting,
branching, and hyperfusion of the capillary network as a result
of excessive tip cell formation. Increased and widespread
expression of Pdgfb, Unc5b, Kdr, Flt4, i.e., genes that are highly
expressed in tip cells, and widespread filopodia formation, the
morphological hallmark of tip cells, provide evidence of the
increased tip cell formation (Hellstrom et al., 2007; Suchting
et al., 2007; Tammela et al., 2008). In zebrafish, GSI treatment,
Dll4 protein knockdown by morpholino oligonucleotide, or
genetic deletion of Dll4 causes excessive vessel sprouting and
branching during the development of intersegmental vessels
and DLAVs (Leslie et al., 2007; Siekmann and Lawson, 2007).
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Endothelial Function Notch Component(s) Involved Reference
Cell specification:
d tip versus stalk
Dll4 Hellstrom et al., 2007; Leslie et al., 2007; Lobov et al., 2007;
Siekmann and Lawson, 2007; Suchting et al., 2007
Notch1 Hellstrom et al., 2007
Rbpja (zebrafish) Siekmann and Lawson, 2007
d arterial versus venous Dll1 Limbourg et al., 2007
Dll4 Duarte et al., 2004; Gale et al., 2004; Krebs et al., 2004;
Trindade et al., 2008
Notch1 Fischer et al., 2004; Kim et al., 2008; Krebs et al., 2000
Notch3 (zebrafish) Lawson et al., 2001
Notch4 Carlson et al., 2005; Kim et al., 2008
Hey1 and Hey2/Gridlock (zebrafish)a Fischer et al., 2004; Zhong et al., 2001
mind bomb (zebrafish) Lawson et al., 2001
Rbpj/Rbpja (zebrafish) Krebs et al., 2004; Siekmann and Lawson, 2007
Proliferation Dll4 Benedito et al., 2008; Liu et al., 2006; Lobov et al., 2007;
Suchting et al., 2007; Trindade et al., 2008
Notch1 Liu et al., 2006
Notch4 Noseda et al., 2004
Rbpj/Rbpja (zebrafish) Dou et al., 2008; Siekmann and Lawson, 2007
Mam1 Liu et al., 2006
Hes1 Liu et al., 2006
Motility Dll4 Leslie et al., 2007; Trindade et al., 2008
rbpja (zebrafish) Siekmann and Lawson, 2007
Filopodia protrusion Dll4 Hellstrom et al., 2007; Leslie et al., 2007;
Lobov et al., 2007; Suchting et al., 2007
Notch1b (zebrafish) Leslie et al., 2007
Matrix production/assembly
and cell adhesion
Dll4 Benedito et al., 2008; Harrington et al., 2008;
Hodkinson et al., 2007; Trindade et al., 2008
Notch1 Hodkinson et al., 2007
Notch4 Leong et al., 2002
Vessel stability Nrarp Phng et al., 2009
Dll4, Delta-like 4; Nrarp, Notch-regulated ankyrin repeat protein; Rbpja, recombinant signal binding protein for immunoglobulin kappa J region a.
a Targeted deletion of Hey2 alone in the mouse does not lead to defects in arterial-venous specification. Arterial differentiation, however, requires the
function of both Hey1 and Hey2 since endothelial cells from mice deficient in both genes fail to establish arterial identity.Excessive branching also occurred when notch1b (Leslie et al.,
2007) and the zebrafish CSL protein rbpja were knocked down
(Siekmann and Lawson, 2007), illustrating that Dll4 signals
through notch1b in an rbpja-dependent manner to limit the
number of endothelial tip cells formed.
Mosaic analysis of endothelial cells deficient in Notch
signaling in mouse and zebrafish demonstrated that Notch is
cell autonomously required for stalk cell specification by actively
suppressing the tip cell phenotype. This cell-autonomous func-
tion of Notch was previously observed in 3D endothelial cell
sprouting assays in vitro (Sainson et al., 2005). In mouse, mosaic
endothelial Cre recombination of a floxed Notch1 allele showed
that the majority of Notch-deficient endothelial cells adopt tip cell
characteristics (Hellstrom et al., 2007). In zebrafish, rbpja-defi-
cient Tg(fli1:EGFP)y1 cells transplanted into wild-type zebrafish
embryos show an increased propensity to occupy the tip cell
position of intersegmental vessels, but have reduced base cell
localization when compared to transplanted wild-type cells
(Siekmann and Lawson, 2007). Conversely, ectopic activationof Notch signaling in the mouse retina by injection of the Jag1
peptide leads to reduced tip cell formation and filopodia exten-
sion (Hellstrom et al., 2007), and endothelial cell clones carrying
a constitutive active NICD are excluded from the tip cell position
in zebrafish (Siekmann and Lawson, 2007).
The results of these experiments also provide an indication
that tip and stalk cells do not represent stable cell fates, but
instead are specified in a dynamic fashion in a process best
described as a ‘‘tug-of-war.’’ Endothelial cells stimulated by
VEGF-A compete for the tip cell position via Dll4/Notch signaling
(Figure 3). The cell that produces more Dll4 than its neighbor will
eventually remain the tip, because it can effectively suppress the
same response in competing neighbors via activation of Notch
signaling. This ‘‘social’’ behavior has previously been described
in Drosophila tracheal development, where the epithelial cells
that form the tracheal sprout compete for the tip position using
FGFR (Breathless) levels and Delta/Notch signaling (Ghabrial
and Krasnow, 2006). It seems that the tip cell phenotype is the
default acquired in the absence of Notch signaling, whereasDevelopmental Cell 16, February 17, 2009 ª2009 Elsevier Inc. 199
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strom et al., 2007; Roca and Adams, 2007).
Studies in several mouse tumor models illustrated that the
principle of tip-stalk specification by Notch signaling is not
restricted to developmental angiogenesis, but also controls the
branching frequency of tumor blood vessels (Noguera-Troise
Figure 3. Notch Signaling Regulates
Endothelial Tip/Stalk Cell Specification
(A and B) In regions of hypoxia, all endothelial cells
become activated by VEGF-A stimulation to
express the Notch ligand Dll4.
(B) Endothelial cells compete via bilateral Dll4-
Notch signaling involving a VEGF-Notch feedback
loop for tip cell specification.
(C) Notch signaling induces lateral inhibition and
gives rise to a nonuniform population of endothe-
lial cells in the presence of VEGF-A stimulation.
(D) Schematic illustration of the VEGF-A-Notch
feedback loop controlling tip-stalk specification:
purple stalk cells receive high Notch signal, which
represses transcription of the VEGF receptors Kdr,
Nrp1, and Flt4, while stimulating expression of the
decoy receptor (s)Flt1; green tip cells receive low
Notch signal, allowing for high Kdr, Nrp1, and
Flt4 expression, but low (s)Flt1 expression.
(E) Notch signaling induces the acquisition of an
endothelial stalk cell, whereas a cell that is low in
Notch activity becomes an endothelial tip cell.
(F) Fluorescent laser scanning micrograph of
sprouting retinal blood vessels of a transgenic
Notch reporter mouse (TNR1). Cells with Notch
signaling are detected by GFP expression (green).
In blood vessels, endothelial cells (Isolectin-B4,
blue) express membranous Dll4 (red) and are he-
teregeneous in Notch activity.
(G and H) In the absence of Notch signaling, stalk
cells are no longer specified; instead, all endothe-
lial cells become tip cells.
et al., 2006; Ridgway et al., 2006). Trans-
plantable tumors in Dll4 heterozygous
hosts show vastly increased sprouting
angiogenesis. Inhibition of Notch
signaling by GSI or selective antibody-
based blocking of Dll4 leads to similar
effects. Analysis of tumor growth
provided an intriguing insight into the func-
tional consequences of excessive tip
cell formation during sprouting angiogen-
esis: the increased vascularization after
Dll4/Notch inactivation paradoxically
causes reduced tumor growth, indicating
that unrestrained angiogenesis is unpro-
ductive (Thurston et al., 2007). Tracer
perfusion experiments demonstrate that
the excessive tumor vessels are poorly
perfused, causing increased tumor
hypoxia and reduced tumor growth. In
a converse experiment, increased endo-
thelial Notch signaling triggered by Dll4-
expressing tumor cells led to reduced
vascular branching and density, but to
enhanced vessel diameter, perfusion,
and therefore augmented tumor growth
(Li et al., 2007; Noguera-Troise et al., 2006). Together, the devel-
opmental and tumor angiogenesis studies support the emerging
concept that effective vascular patterning and function require
a balance of tip and stalk cell numbers coordinated by Notch.
How exactly Notch suppresses tip cell formation is not fully
resolved. Accumulating evidence suggests a model in which200 Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc.
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in endothelial cells at least in part through the transcriptional
regulation of Flt1, Kdr, Nrp1, and Flt4 (reviewed in Siekmann
et al., 2008) (Figure 3). Collectively, data gathered from in vitro
and in vivo studies demonstrate that Notch negatively regulates
Kdr expression (Harrington et al., 2008; Henderson et al., 2001;
Li et al., 2006; Suchting et al., 2007; Williams et al., 2006), likely
through the direct binding of Hey1 to the Kdr promoter (Hender-
son et al., 2001; Holderfield et al., 2006). Nrp1 is also repressed
by Notch, whereas the VEGF-A decoy receptor Flt1, which can
quantitatively and spatially modulate Kdr signaling (Kappas
et al., 2008), is upregulated by Dll4/Notch signaling. In addition,
the soluble splice variant of Flt1 (sFlt1) is upregulated upon
Notch activation in endothelial cells (Harrington et al., 2008),
suggesting that active Notch signaling could potentially reduce
or spatially restrict the overall response of endothelial cells to
VEGF-A through the sequestration of extracellular VEGF-A.
In the adult organism, Flt4 expression is largely confined to the
lymphatic endothelium, where it acts as a signaling receptor for
VEGF-C. However, during embryonic development, Flt4 plays an
important role in VEGF signaling in the blood vasculature,
possibly by forming heterodimers with Kdr. Flt4 is strongly
expressed in zebrafish intersegmental vessels (Siekmann and
Lawson, 2007), at the tips of ISVs in mouse embryos, at the
sprouting front in mouse retina, and in sprouting tumor vessels
(Tammela et al., 2008). Intriguingly, loss of Notch signaling leads
to widespread Flt4 expression, and blocking antibodies against
Flt4 partially restored normal sprouting. Although these studies
suggest that Flt4 is downregulated in the endothelial stalk by
Notch signaling activity, a study in cultured endothelial cells
demonstrated direct activation of the Flt4 promoter by the
NICD/CSL complex (Shawber et al., 2007). More work is required
to clarify exactly how and under which conditions Notch
signaling regulates the different VEGF receptors.
The complexity of the relationship between Notch and VEGF
signaling pathways is also illustrated by the discovery that
VEGF induces Dll4 expression through Kdr in the retina (Liu
et al., 2003; Lobov et al., 2007; Suchting et al., 2007) and endo-
thelial cultures (Liu et al., 2003). Mechanistically, at least in
arterial endothelium, VEGF signaling activates Dll4 transcription
through phosphoinositide 3 kinase (PI3K) and Erk signaling in
collaboration with Foxc transcription factors (Hayashi and
Kume, 2008; Seo et al., 2006). VEGF and Notch pathways thus
operate a negative-feedback loop in which (i) VEGF-A triggers
endothelialDll4 expression, and (ii) Dll4 activates Notch signaling
in adjacent cells, leading (iii) to the downregulation of VEGF
receptors and thus of the VEGF response (Figure 3). Computa-
tional modeling of tip cell selection illustrated that this feedback
loop is sufficient to pattern a row of endothelial cells stimulated
by adequate concentrations of VEGF-A into alternating tip and
stalk cells (Bentley et al., 2008). This study also suggested that
VEGF-A gradients and filopodia formation confer robustness to
VEGF/Dll4/Notch-dependent tip-stalk specification.
Notch Signaling and Endothelial Proliferation
The formation of a new vessel requires not only the selection of
an endothelial tip cell, but also endothelial cell proliferation to
enable sprout growth in length and diameter. There is ample
evidence that the Notch pathway inhibits proliferation in endo-thelial cells. Suppression of Notch signaling results in increased
endothelial cell proliferation in 3D sprouting assays in vitro (Sain-
son et al., 2005), in mouse and zebrafish development in vivo
(Hellstrom et al., 2007; Leslie et al., 2007; Lobov et al., 2007;
Siekmann and Lawson, 2007; Suchting et al., 2007), in the adult
mouse (Dou et al., 2008), and during tumor angiogenesis
(Noguera-Troise et al., 2006; Ridgway et al., 2006). In mouse,
increased endothelial cell proliferation of both tip and stalk cells
may contribute to increased vessel diameter and branching after
GSI treatment (Hellstrom et al., 2007), after neutralization of Dll4
activity by Dll4-Fc (Lobov et al., 2007), and in Dll4+/ mutants
(Suchting et al., 2007). In zebrafish, the increase in proliferation
and the aberrant migratory behavior of endothelial cells resulted
in an increased number of endothelial cells in intersegmental
vessels in rbpja-deficient zebrafish (Siekmann and Lawson,
2007). Conversely, stimulation of Notch signaling in endothelial
cells in vitro (Liu et al., 2006; Noseda et al., 2004) and in mouse
decreased endothelial cell proliferation (Harrington et al., 2008;
Trindade et al., 2008).
Studies in endothelial cell cultures suggest that the inhibitory
effect of Notch signaling on endothelial cell proliferation is medi-
ated by the transcriptional regulation of downstream targets of
the NICD/CSL/MAML complex (Liu et al., 2006). The inhibition
may be caused by a decrease in the activation of the MAPK
and PI3K/Akt signaling pathways involving MAML1-mediated
transcription of target genes. Liu et al. proposed that Notch
signaling regulates MAPK and PI3K/Akt indirectly through differ-
ential regulation of Flt1 and Kdr, thereby reducing Kdr-mediated
MAPK and PI3K/Akt signaling. Notch signaling also regulates the
expression of the cyclin-dependent kinase inhibitor p21CIP1 in
endothelial cells (Noseda et al., 2004). p21CIP1 expression is
downregulated by Notch1 and Notch4 activity, resulting in
a reduction in the nuclear translocation of cyclin D and cdk4, in
the downregulation of cyclin D-cdk4-mediated Rb phosphoryla-
tion, and, consequently, in cell cycle arrest (Dou et al., 2008;
Noseda et al., 2004). Conversely, endothelial deletion of RBP-J
in adult mice induced p21CIP1 and endothelial cell proliferation
(Dou et al., 2008).
The regulation of cell proliferation by Notch signaling shows
cell-type-dependent differences. For example, in cardiomyo-
cytes (Collesi et al., 2008; Campa et al., 2008) and keratinocytes
(Rangarajan et al., 2001), Notch signaling promotes cell cycle
progression. Also, the regulatory role of p21CIP1 in cell cycle
progression is cell type dependent since Notch signaling
induces the transcription of p21CIP1 in an RBP-J-dependent
manner to promote cell proliferation of keratinocytes (Rangara-
jan et al., 2001).
Notch Signaling and Cell Motility/Filopodia Formation
Filopodia are involved in a number of cellular processes such as
adhesion to extracellular matrices, guidance toward chemoat-
tractants, and cell migration. A prominent phenotype that arises
from the suppression or overactivation of Notch signaling in
endothelial cells is an increase or decrease in filopodia protru-
sion, respectively, suggesting a role of Notch in regulating endo-
thelial cell motility (Figure 4). Overactivation of Notch signaling
reduces the migratory behavior of endothelial cells. In mice over-
expressing Dll4, there is decreased endothelial cell migration
and sprouting from the dorsal aorta to form intersomitic vesselsDevelopmental Cell 16, February 17, 2009 ª2009 Elsevier Inc. 201
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(A–C) (A) Suppression of Notch signaling leads to a significant increase in filopodia protrusion by endothelial tip cells, whereas an ectopic increase of Notch
signaling results in (C) a decrease in filopodia formed when compared to (B) normal vessels. Early postnatal mice were treated with the g-secretase inhibitor
DAPT to inhibit Notch signaling or the Jag1 peptide, which corresponds to the DSL domain of the human Jag1 protein, to activate Notch receptor. Retinas
have been stained with Isolectin-B4. Scale bars represent 10 mm.(ISVs) (Trindade et al., 2008). In vitro, human umbilical vein endo-
thelial cells (HUVECs) expressing full-length Dll4 exhibit
decreased motility in the presence of exogenous VEGF (Trin-
dade et al., 2008). Similarly, in zebrafish, overexpression of the
NICD inhibited the migration and filopodia activity of endothelial
cells (Leslie et al., 2007; Siekmann and Lawson, 2007). Further-
more, when Tg(fli1:EGFP)y1 cells with activated Notch were
transplanted into wild-type zebrafish embryos, these cells
showed increased incorporation at the base of the ISV, but did
not occupy positions in the dorsal longitudinal anastomotic
vessels (DLAV) (Siekmann and Lawson, 2007).
How does Notch signaling regulate endothelial cell motility?
As Notch signaling downregulates Kdr, Flt4, and Nrp1 levels, it
could potentially reduce endothelial cell motility by making cells
less responsive to VEGF-A. However, it is not yet clear whether
the levels of VEGF receptors could directly influence endothelial
cell motility. The levels of the ligand, VEGF-A, appear to be rate
limiting for endothelial cell proliferation, in part through quantita-
tive activation of Erk1/2 (Gille et al., 2001), but endothelial
migration is not likely to depend on absolute levels of VEGF-A.
Endothelial cell migration is regulated by several signaling
pathways, including PI3K, which are activated by the phosphor-
ylation of distinct VEGFR2 tyrosine residues (for an overview, see
Olsson et al., 2006). PI3K inhibitors quantitatively suppress
endothelial cell migration (Gille et al., 2001; Graupera et al.,
2008), and genetic inactivation of the p110a isoform of the class
IA PI3K illustrated that p110a is selectively required for endothe-
lial migration, but not proliferation, downstream of VEGFR
activation (Graupera et al., 2008). P110a regulates endothelial
cell migration by activation of the small GTPase RhoA. Notably,
blocking of the Semaphorin and VEGF co-receptor Nrp-1 by
antibodies selectively abrogates VEGF-induced endothelial
migration, but not proliferation (Pan et al., 2007), and the
C-terminal domain of Nrp-1 stimulates endothelial migration
via PI3K, Akt, and RhoA (Wang et al., 2003). Nrp1 knockout
mice show defects in endothelial cell migration and endothelial
tip cell guidance, but not proliferation (Gerhardt et al., 2004;
Jones et al., 2008). Nrp1 is strongly downregulated by Notch
signaling (Harrington et al., 2008; Williams et al., 2006), suggest-
ing that Notch could suppress endothelial motility by modulating202 Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc.coreceptors for VEGF-A, which play a particular role in endothe-
lial migration.
Alternatively—and not yet tested in endothelial cells—Notch
could regulate cell motility more directly in a CSL-independent
manner. InDrosophila, Notch receptors can activate the Abl tyro-
sine kinase to stimulate neuronal migration and axonal guidance
(Crowner et al., 2003; Le Gall et al., 2008). Abl performs its func-
tions in cooperation with a range of proteins, such as Disabled
and the guanine nucleotide-exchange factor Trio, which alleviate
or enhance the severity of defects observed in Drosophila Abl
mutants. Notch binds directly to Disabled and Trio to regulate
Abl signaling. Similarly, the mouse homolog Disabled 1 binds
to the intracellular domain of Notch1 in embryonic brain lysates
(Hashimoto-Torii et al., 2008). In Drosophila, specific deletion
of the Disabled-binding domain in Notch resulted in defects in
embryonic axon patterning, a process that requires axon guid-
ance and migration, with little or no effect on neurogenesis
(Le Gall et al., 2008). In addition, the canonical Notch signaling
pathway appeared to be dispensable for axonal function. There-
fore, although axon patterning and neurogenesis are both
dependent on Notch signaling, the underlying mechanisms
seem to be distinct. In the former case, a CSL-independent
pathway that involves Disabled and Abl is required, whereas in
the latter case, the canonical CSL-dependent pathway is impor-
tant. Given the functional and molecular similarities between
axonal guidance and endothelial tip cell guidance, it is tempting
to speculate that a similar CSL-independent pathway involving
Disabled and Abl may regulate endothelial cell motility down-
stream of Notch.
Notch Signaling and Cell Adhesion
In vertebrates, Notch receptor activation can also be modulated
by non-DSL ligands. Of particular interest is microfibril-associ-
ated glycoprotein (MAGP)-2, a small glycoprotein that specifi-
cally associates with fibrillin-containing microfibrils (Gibson
et al., 1996) and promotes cell adhesion in a variety of cell types,
including bovine arterial endothelial cells, by binding to avb3
integrin (Gibson et al., 1999). More recently, MAGP-2 has been
shown to bind directly to Jag1, Jag2, and Dll1 (Nehring et al.,
2005) and also to Notch1 (Miyamoto et al., 2006). Binding of
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and, in the case of Notch1, MAGP-2 binding induces g-secre-
tase-dependent NICD generation and CSL-dependent activa-
tion of Notch signaling (Albig et al., 2007, 2008; Miyamoto
et al., 2006). However, the regulatory role of MAGP-2 on Notch
signaling is cell type dependent. In nonendothelial cells such
as COS7 (Miyamoto et al., 2006) and various tumor cell lines
(Albig et al., 2008), MAGP-2 induces Notch signaling. However,
MAGP-2 suppresses Notch signaling in several endothelial cell
lines, including HUVEC and MB114 (Albig et al., 2008). Interest-
ingly, MAGP-2 has an angiogenic function; it is able to promote
endothelial cell sprouting in vitro by antagonizing Notch signaling
(Albig et al., 2007, 2008). However, the expression pattern of
MAGP-2 in developing vessels and their extracellular milieu is
as yet unknown, and a role in vessel patterning in vivo remains
to be shown.
There is also some evidence that Notch signaling regulates the
expression of extracellular matrix molecules. For example, there
is increased transcription of fibronectin, laminin, and collagen in
endothelial cells isolated from mouse embryos overexpressing
Dll4 (Trindade et al., 2008). As a result, these mutants show
increased deposition of extracellular matrix around the dorsal
aorta. Conversely, Dll4+/ mouse embryos show decreased
expression and irregular deposition of collagen IV and laminin
(Benedito et al., 2008). Harris and colleagues also observed
significant regulation of integrin expression by Notch signaling
in endothelial cells (Harrington et al., 2008). Together, these
results illustrate that Notch can influence both matrix production
and adhesive properties in the form of integrin receptor expres-
sion, although, again, the full in vivo significance remains to be
examined. The induction of extracellular matrix components
that stabilize the vessel wall is consistent with the arterial spec-
ification effect of Notch.
Although most Notch signaling is mediated by the CSL-
dependent pathway, there is growing evidence that the activa-
tion of Notch receptor also triggers cellular responses through
CSL-independent pathways. One such pathway is the activation
of b1-integrins by Notch1 (Hodkinson et al., 2007). This mecha-
nism still relies on the production of NICD1 from g-secretase-
mediated cleavage of the Notch receptor. NICD1 specifically
activates R-Ras, which antagonizes H-Ras-mediated integrin
suppression to increase integrin affinity (Hodkinson et al.,
2007). The increase in integrin activity enhances cell adhesion
Figure 5. Notch Confers Vessel Stability
through Nrarp
(A and B) Loss of Nrarp leads to excessive segre-
gation of endothelial junctions (arrows) and vessel
instability. Postnatal day 5 retinas were stained for
Claudin 5 (green), Collagen IV (red), and Isolectin-
B4 (blue). Scale bars represent 25 mm.
to extracellular matrix proteins. For
example, human myeloid cells that have
been transfected with NICD1 or that
have been activated with recombinant
Dll4 exhibit increased adhesion to fibro-
nectin (Hodkinson et al., 2007). In addi-
tion, overexpression of the intracellular
domain of Notch4 (NICD4) in endothelial cells results in a b1
integrin-mediated increase in adhesion to collagen, and these
cells show a reduced sprouting response to VEGF both in vitro
and in vivo (Leong et al., 2002). The activation of R-Ras does
not require CSL-mediated transcription and may therefore trans-
mit rapid changes in cellular signaling in response to interaction
with Notch ligands expressed on adjacent cells (Hodkinson
et al., 2007).
Notch Signaling and Vessel Stability
As part of the overall sprouting angiogenesis process, newly
generated vessels are stabilized to form a functional vascular
network. Once a vascular network is established, endothelial
cells become quiescent to prevent excessive vessel sprouting.
Recent studies showed that loss of Rbpj in endothelial cells in
adults reinitiated vascular outgrowth from existing vessels (Dou
et al., 2008), demonstrating that Notch signaling has a regulatory
role in maintaining endothelial cell quiescence.
Furthermore, we recently found that a downstream target of
the Notch pathway, Nrarp (Krebs et al., 2001; Lamar et al.,
2001; Pirot et al., 2004), stabilizes nascent blood vessels during
retinal angiogenesis and intersegmental vessel formation in
zebrafish (Phng et al., 2009). Nrarp/ mice and zebrafish mor-
phants show reduced endothelial cell proliferation and excessive
junctional rearrangement within nascent blood vessels—defects
that culminate in ectopic vessel regression during sprouting
angiogenesis and thus reduced vessel density (Figure 5). Nrarp
is directly induced by Notch signaling, but it functions as a nega-
tive regulator by promoting the degradation of NICD (Ishitani
et al., 2005; Lamar et al., 2001). Accordingly, loss of Nrarp leads
to increased Notch activity, potentially explaining the reduced
stalk cell proliferation and the opposing phenotype to that seen
with the loss of Rbpj function in endothelial cells. Remarkably,
however, this increased Notch signaling does not affect endo-
thelial sprouting activity or filopodia formation, probably
because it occurs only in the stalk, leaving the tip cells unaffected
(Phng et al., 2009). Increased Notch signaling per se does not
appear to cause vessel regression or loss of stability. Instead,
our study suggests that the stabilization of nascent vessels
requires Nrarp-mediated promotion of canonical Wnt signaling
via stabilization of the b-catenin cofactor TCF/Lef-1, and that
Notch and Wnt signaling are coordinated by Nrarp in stalk cells
to control the stability of newly formed vessel connectionsDevelopmental Cell 16, February 17, 2009 ª2009 Elsevier Inc. 203
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(A–D) (A and C) Notch signaling induces the expression of basement membrane components such as collagen IV and laminin, which are concentrated along stalk
cells. (B) Loss of the downstream Notch target gene Nrarp leads to vessel instability and regression as a result of reduced endothelial cell proliferation and junc-
tional rearrangement, leaving behind empty basement sleeves (arrow). (C) Although Notch signaling represses endothelial cell proliferation in stalk cells, Wnt
signaling promotes cell cycle progression by, for example, positively regulating the expression of Cyclin D1. (A and C) As Nrarp expression is high in stalk cells
and it enhances Wnt signaling by stabilizing Lef1, stalk cells undergo high proliferation. Tip cells, compared to stalk cells, are highly motile and migrate following
a gradient of VEGF-A expression. (C) The migratory activity of tip cells is regulated by KDR-induced p110a activity, whereas the proliferative activity of stalk cells is
largely influenced by ERK1/2 activity. (D) Different endothelial cell responses to environmental signals, such as hypoxia and VEGF-A, are coordinated by Notch
signaling. The unifying outcome of Notch signaling in endothelial cells is the generation of patent and well-perfused vessels to relieve hypoxia.(Phng et al., 2009). One important component of the stability
program appears to be the control of endothelial cell proliferation
through Notch/Nrarp and Wnt crosstalk (Figure 6). In contrast to
Notch signaling, activation of Wnt signaling promotes endothe-
lial cell proliferation (Masckauchan et al., 2005, 2006) and the
b-catenin/Lef1 complex can directly activate the transcription
of Cyclin D1 to induce cell cycle progression (Shtutman et al.,
1999). Whereas Notch signaling appears to regulate the output
of the VEGF signaling pathway promoting quiescence, Nrarp
modulates the output of Notch and Wnt to allow for sufficient
proliferation during vessel stabilization (Figure 6). The Wnt
ligands involved in vivo are currently unknown, but Wnt7a and
Wnt7b are potential candidates, as their deletion from neuroepi-
thelium results in impaired CNS vascularization (Stenman et al.,
2008). The question of how general this crosstalk may be for204 Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc.coordinated angiogenesis in other organ systems or in tumor
angiogenesis requires further investigation.
The positive regulation of endothelial basement membrane
components by Notch signaling (Benedito et al., 2008; Trindade
et al., 2008) will likely also contribute to the stability of nascent
vessels (Figure 6). However, regressing vessels leave empty
basement membrane sleeves behind (Baffert et al., 2006)
(Figure 5), suggesting that the basement membrane alone is
not sufficient to promote vessel stability.
Conclusions and Perspectives
Combined information from a wealth of recent studies has led to
the conclusion that Notch signaling plays a pivotal role in the
control of vascular morphogenesis during development and in
tumor angiogenesis. The precise function of Notch is difficult
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multiple aspects of endothelial cell biology, which superficially
appear to have little in common. The varied demonstrated func-
tional roles, including specification of angioblasts from the lateral
mesoderm, specification of arterial and venous endothelial cell
populations in the early assembly of dorsal aorta and cardinal
vein, and the selection of tip and stalk cells during subsequent
angiogenic sprouting, suggest that endothelial cells reiteratively
engage Notch signaling at various stages of development, and
even require continued Notch activity to maintain quiescence
in adult vessels. Also, at the molecular level, Notch appears to
regulate and crosstalk with multiple signaling pathways that
operate in endothelial cells in a context-dependent manner.
Our understanding of defined genetic interactions of Notch in
vascular development is most advanced for its role in artery
vein formation. The more recent identification of Notch control-
ling tip versus stalk selection to pattern the sprouting response
still lacks detailed mapping of many components, and we expect
rapid progress in this area over the next few years.
We also anticipate that investigation of the dynamics of Notch
signaling in endothelial cells will receive greater attention, as it
may explain how Notch controls the spatiotemporal patterning
events in angiogenesis. For example, oscillations of Notch
signaling have been observed in several other organ systems,
in particular vertebrate somitogenesis, as well as in isolated cells
during neurogenesis (Kageyama et al., 2007). Although these
oscillations may be tied to oscillations of other pathways, such
as Wnt, the intrinsic properties of selective Notch targets,
including transcriptional repressors of the Hes family, may be
important for the periodicity of the oscillations, which control,
for example, the spacing of tissue boundaries during somitogen-
esis (Jiang et al., 2000; Lewis, 2003). The conspicuous spatial
expression pattern of Dll4 in arteries and in sprouting vessels
has implications for temporal aspects of endothelial Notch
signaling. The alternating stripes of high and low Dll4 in arteries
are unlikely to be static over time. Conceptually, Dll4-high endo-
thelial cells should have low Notch activity, whereas their neigh-
bors will have high Notch activity, but low Dll4 expression. As
Notch signaling is required for the specification and maintenance
of arterial identity, continuously low Notch activity in a subset of
endothelial cells along the artery would lead to a loss of identity.
Coordinated oscillations, similar to the situation in the presomitic
mesoderm, could theoretically produce a wave of Dll4 expres-
sion running the length of arteries, providing recurring Notch
input in each cell to stabilize the arterial phenotype. Similarly,
in static images of sprouting vessels, Dll4 expression is not
always found in the tip, and Notch reporter activity is not always
confined to the stalk. One intriguing possibility is that negative-
feedback loops within the Notch signaling pathway itself are
the primary reason for reiterative sprouting and branching during
angiogenesis. Dynamic regulation of Notch signaling could
therefore be as important for the spatial patterning of branching
in angiogenesis as it is in the spatial patterning of somites.
The precise phenotypic outcome of Notch activity in endothe-
lial cells appears to be context dependent, but one common
underlying theme may be that Notch signaling promotes cellular
responses in endothelial cells that are collectively suited to
establish and maintain increased perfusion and hence alleviate
hypoxia (Figure 6D). Although this may appear to be the obviousaim of all signaling that promotes angiogenesis, the lessons
learned from Notch signaling tell us otherwise. VEGF-A signaling
triggers endothelial sprouting, migration, proliferation, cell
survival, and thus vessel maintenance, and it is important for
artery formation, lumen formation, and more. However,
in situations in which Notch signaling is absent or reduced, for
example in Dll4 heterozygous animals, no functional vessel
patterning and perfusion can occur and hypoxia/ischemia
persists. Without Notch signaling, endothelial cells expand,
migrate, and produce filopodia to make new connections, i.e.,
all responses suited to providing more building material for
new blood vessels. Notch activity is required to coordinate these
efforts so that a functional and perfused network of arteries and
capillary tubes can meet the tissue demands for nutrients and
oxygen. To this end, Notch interacts with various other pathways
(including Wnt) at many levels, and, at this point, we have likely
only scratched the surface of the complex signaling network
that controls endothelial cell responses in conjunction with
Notch.
One important principle of the signaling network emerges: the
signals from the tissue in need of new blood vessels, i.e., hypoxia
and hypoxia-regulated growth factors such as VEGF-A, induce
both the sprouting response and the production of the Notch
ligand required to coordinate the response into functional tubular
morphogenesis. Mounting evidence from studies in mouse and
fly shows that hypoxic signaling cooperates directly with Notch,
controlling cellular behavior and metabolism to cope with
hypoxic stress (Poellinger and Lendahl, 2008; Zhou et al.,
2008) (see also Fraisl et al., 2009). A deeper understanding of
these fundamental principles will undoubtedly aid in the devel-
opment of new avenues for the treatment of blood vessel-related
pathologies. The important challenges ahead include decipher-
ing which Notch signaling components function in endothelial
cells in vivo during control of the different aspects of endothelial
cell biology.
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